A Study of I-DXd in Combination With Atezolizumab With or Without Carboplatin as First-Line Induction or Maintenance in Subjects With Extensive Stage-Small Cell Lung Cancer (IDeate-Lung03)
Public ClinicalTrials.gov record NCT06362252. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Phase 1b/2, Multicenter, Open-label Study of Ifinatamab Deruxtecan (I-DXd), a B7-H3 Antibody-Drug Conjugate (ADC), in Combination With Atezolizumab With or Without Carboplatin as First-line Induction or Maintenance, in Subjects With Extensive-stage Small Cell Lung Cancer (ES-SCLC) (IDeate-Lung03)
Study identification
- NCT ID
- NCT06362252
- Recruitment status
- Recruiting
- Study type
- Interventional
- Phase
- Phase 1, Phase 2
- Lead sponsor
- Daiichi Sankyo
- Industry
- Enrollment
- 123 participants
Conditions and interventions
Conditions
Interventions
- Ifinatamab deruxtecan Drug
- Atezolizumab Drug
- Carboplatin Drug
Drug
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Jul 21, 2024
- Primary completion
- Sep 29, 2026
- Completion
- Dec 29, 2026
- Last update posted
- Feb 5, 2026
2024 – 2026
United States locations
- U.S. sites
- 26
- U.S. states
- 15
- U.S. cities
- 22
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| University of Alabama -Birmingham | Birmingham | Alabama | 35233 | Recruiting |
| Mayo Clinic Arizona | Phoenix | Arizona | 85054 | Recruiting |
| David Geffen School of Medicine | Los Angeles | California | 90095 | Not yet recruiting |
| Hoag Memorial Hospital Presbyterian | Newport Beach | California | 92663 | Recruiting |
| Mayo Clinic-Jacksonville | Jacksonville | Florida | 32224 | Recruiting |
| Advent Health Orlando | Orlando | Florida | 32804 | Recruiting |
| Moffitt Cancer Center | Tampa | Florida | 33612 | Recruiting |
| Robert H. Lurie Comprehensive Cancer Center of Northwestern University | Chicago | Illinois | 60611 | Recruiting |
| Henry Ford Hospital | Detroit | Michigan | 48202 | Active, not recruiting |
| Regents of the University of Minnesota | Minneapolis | Minnesota | 55455 | Recruiting |
| Mayo Clinic | Rochester | Minnesota | 55905 | Recruiting |
| Dartmouth-Hitchcock Medical Center | Lebanon | New Hampshire | 03766 | Recruiting |
| Astera Cancer Care | East Brunswick | New Jersey | 08816 | Recruiting |
| John Theurer Cancer Center At Hackensack Umc | Hackensack | New Jersey | 07601 | Recruiting |
| New York University Cancer Center - Laura and Isaac Perlmutter Cancer Center At Nyu Langone | Mineola | New York | 11501 | Recruiting |
| NYU Langone Hospital - Long Island | Mineola | New York | 11501 | Recruiting |
| Memorial Sloan Kettering Cancer Center | New York | New York | 10021 | Recruiting |
| Columbia University Hervert Irving Comprehensive Cancer Center | New York | New York | 10032 | Recruiting |
| Montefiore Medical Center | New York | New York | 10461 | Recruiting |
| Lancaster General Hospital - Ann B Barshinger Cancer Institute | Lancaster | Pennsylvania | 17601 | Recruiting |
| University of Pennsylvania, Abramson Cancer Center | Philadelphia | Pennsylvania | 19104 | Recruiting |
| Thomas Jefferson University Hospital - Central | Philadelphia | Pennsylvania | 19107 | Recruiting |
| Scri Oncology Partners | Nashville | Tennessee | 37203 | Recruiting |
| Next Virginia | Fairfax | Virginia | 22031 | Recruiting |
| Northwest Cancer Specialists, P.C.-Vancouver | Vancouver | Washington | 98684 | Recruiting |
| Medical College of Wisconsin | Milwaukee | Wisconsin | 53226 | Recruiting |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 32 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT06362252, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Feb 5, 2026 · Synced Jun 25, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT06362252 live on ClinicalTrials.gov.